Review of Access to New Medicines (Montgomery review)

On December 14, The Scottish Government released the long-awaited “Review of Access to New Medicines in Scotland”, headed by Dr Brian Montgomery.

The review sets out that access to end-of-life, orphan and ultra-orphan medicines has increased as a result of the 2014 system updates and the availability of funding via the New Medicines Fund. Stakeholder satisfaction with the SMC process is generally high. There were, however, some notable issues raised, particularly relating to the assessment of ultra-orphan medicines and the need for a sustainable system that takes affordability into account and is better aligned with the Chief Medical Officer’s “Realistic Medicine” proposition.

Tagged with

Published 16. December 2016 in News UK